Achieve Life Sciences, Inc.

NasdaqCM:ACHV Stock Report

Market Cap: US$147.5m

Achieve Life Sciences Balance Sheet Health

Financial Health criteria checks 4/6

Achieve Life Sciences has a total shareholder equity of $31.4M and total debt of $9.8M, which brings its debt-to-equity ratio to 31.3%. Its total assets and total liabilities are $47.9M and $16.5M respectively.

Key information

31.3%

Debt to equity ratio

US$9.82m

Debt

Interest coverage ration/a
CashUS$42.91m
EquityUS$31.38m
Total liabilitiesUS$16.54m
Total assetsUS$47.92m

Recent financial health updates

Recent updates

Achieve Life Sciences: 1st Half 2025 NDA Filing On Track With FDA Agreement

Jul 01

Does Achieve Life Sciences (NASDAQ:ACHV) Have A Healthy Balance Sheet?

Jan 27
Does Achieve Life Sciences (NASDAQ:ACHV) Have A Healthy Balance Sheet?

Is Achieve Life Sciences (NASDAQ:ACHV) Using Debt In A Risky Way?

Oct 26
Is Achieve Life Sciences (NASDAQ:ACHV) Using Debt In A Risky Way?

Is Achieve Life Sciences (NASDAQ:ACHV) A Risky Investment?

Mar 26
Is Achieve Life Sciences (NASDAQ:ACHV) A Risky Investment?

Achieve Life Sciences begins phase 2 trial testing cytisinicline for nicotine e-cigarette cessation

Jun 29

Achieve Life Sciences: Initiating Buy, Potential Multi-Billion-Dollar Smoking Cessation Drug

Apr 04

Is Achieve Life Sciences (NASDAQ:ACHV) Weighed On By Its Debt Load?

Mar 22
Is Achieve Life Sciences (NASDAQ:ACHV) Weighed On By Its Debt Load?

Is Achieve Life Sciences (NASDAQ:ACHV) In A Good Position To Deliver On Growth Plans?

Sep 27
Is Achieve Life Sciences (NASDAQ:ACHV) In A Good Position To Deliver On Growth Plans?

We Think Achieve Life Sciences (NASDAQ:ACHV) Needs To Drive Business Growth Carefully

Jun 14
We Think Achieve Life Sciences (NASDAQ:ACHV) Needs To Drive Business Growth Carefully

We're Keeping An Eye On Achieve Life Sciences' (NASDAQ:ACHV) Cash Burn Rate

Mar 01
We're Keeping An Eye On Achieve Life Sciences' (NASDAQ:ACHV) Cash Burn Rate

Achieve Life Sciences prices stock offering at $7; shares down 2%

Dec 03

Achieve Life Sciences launches equity offering

Nov 30

Financial Position Analysis

Short Term Liabilities: ACHV's short term assets ($45.5M) exceed its short term liabilities ($6.7M).

Long Term Liabilities: ACHV's short term assets ($45.5M) exceed its long term liabilities ($9.8M).


Debt to Equity History and Analysis

Debt Level: ACHV has more cash than its total debt.

Reducing Debt: ACHV's debt to equity ratio has increased from 0% to 31.3% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: ACHV has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: ACHV has less than a year of cash runway if free cash flow continues to reduce at historical rates of 15.7% each year


Discover healthy companies